Astrana Health, Inc.
ASTHNasdaqCIK 1083446IndustrialsFiscal year ends Dec 31
Reports and events: 370 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2308:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-109822 |
| 2026-09-2307:30 ET | 8-K | 1.05 Material cybersecurity incident | 0001104659-26-109813 |
| 2026-09-1508:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-107730 |
| 2026-08-1017:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342631 |
| 2026-08-0616:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092003 |
| 2026-07-1308:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082892 |
| 2026-07-0116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-079874 |
| 2026-06-1016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072343 |
| 2026-05-1206:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-058922 |
| 2026-05-1206:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058914 |
| 2026-05-0806:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213157 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057134 |
| 2026-04-1706:01 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001104659-26-044536 |
| 2026-03-3017:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036862 |
| 2026-03-1208:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-103128 |
| 2026-03-0407:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-023176 |
| 2026-03-0207:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021893 |
| 2026-01-1216:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002866 |
| 2025-11-1016:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274359 |
| 2025-11-0616:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-107754 |
| 2025-09-1107:20 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-25-089230 |
| 2025-08-0717:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105242 |
| 2025-08-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075194 |
| 2025-07-0207:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-065009 |
| 2025-06-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-058542 |
| 2025-06-0406:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056164 |
| 2025-05-1316:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-047838 |
| 2025-05-0917:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068198 |
| 2025-05-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046125 |
| 2025-04-2516:15 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001104659-25-039438 |
| 2025-03-2806:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-028969 |
| 2025-03-1408:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-039122 |
| 2025-03-1407:47 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023741 |
| 2025-03-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-021981 |
| 2025-03-0308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-019499 |
| 2025-02-2716:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018268 |
| 2025-02-2716:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-018221 |
| 2025-02-1821:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-014908 |
| 2025-01-2219:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-005340 |
| 2025-01-2108:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-004739 |
| 2025-01-1408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003293 |
| 2024-11-1408:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-118357 |
| 2024-11-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-116826 |
| 2024-11-1214:22 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125133 |
| 2024-11-0817:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-115969 |
| 2024-11-0808:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115610 |
| 2024-11-0717:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115381 |
| 2024-10-0709:15 ET | 8-K | 8.01 Other events | 0001104659-24-106504 |
| 2024-09-0418:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096952 |
| 2024-08-0918:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094262 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.